Guanidinobenzamides

US6638927B2 · kind B2 · utility

Assignee

• Chiron Corporation · US

Inventors

• Paul A. Renhowe · Danville, US
• Daniel Chu · Santa Clara, US
• Rustum Boyce · San Francisco, US
• Zhi-Jie Ni · Fremont, US
• David Duhl · Newington, US
• Effie Tozzo · Newton, US
• Kirk W. Johnson · Berkeley, US
• David C. Myles · Kensington, US

Key dates

• Filing date: Aug 31, 2001
• Grant date: Oct 28, 2003
• Expiry date: Oct 29, 2021

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C2603/74
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Compounds of formula IA and IB are new where the variables R1 through R10 have the values set forth herein. Such compounds have use in treating diseases such as obesity and type II diabetes, and may be provided as pharmaceutical formulations in conjunction with a pharmaceutically acceptable carrier.